CÉLULAS MADRE Y TERAPIA CELULAR
Université Libre de Bruxelles
Bruselas, BélgicaPublikationen in Zusammenarbeit mit Forschern von Université Libre de Bruxelles (7)
2019
-
Correction: The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin–Siris syndrome (Genetics in Medicine, (2019), 21, 6, (1295-1307), 10.1038/s41436-018-0330-z)
Genetics in Medicine
-
The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin–Siris syndrome
Genetics in Medicine, Vol. 21, Núm. 6, pp. 1295-1307
2015
-
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1
American Journal of Medical Genetics, Part A, Vol. 167, Núm. 2, pp. 296-312
2013
-
A comprehensive molecular study on coffin-siris and nicolaides-baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling
Human Molecular Genetics, Vol. 22, Núm. 25, pp. 5121-5135
-
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: A case-control study
The Lancet Neurology, Vol. 12, Núm. 12, pp. 1159-1169
2009
-
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response
Nature Genetics, Vol. 41, Núm. 7, pp. 829-832
2007
-
Clinical and molecular phenotype of Aicardi-Goutières syndrome
American Journal of Human Genetics, Vol. 81, Núm. 4, pp. 713-725